Literature DB >> 8463038

Sertoli-Leydig cell tumors of the ovary: review with emphasis on historical aspects and unusual variants.

R H Young1.   

Abstract

Among the many contributions to gynecological pathology of Dr. Robert Meyer were his observations on Sertoli-Leydig cell tumors and the formulation of a classification of them that is the basis of the one used today. Selected variants in this category of tumors are reviewed here. Sertoli cell tumors are of interest clinically because, in contrast to other tumors in this category, they tend to be estrogenic rather than androgenic. They are important for the pathologist to be aware of, because other neoplasms of diverse types may mimic them. Heterologous Sertoli-Leydig cell tumors are noteworthy; since they may feature mucinous epithelium, carcinoid, skeletal muscle, and/or cartilage, they may present a confusing histologic picture that could result in a misdiagnosis. Similarly, the recently recognized retiform variant of Sertoli-Leydig cell tumor is apt to be misdiagnosed because its pattern of slit-like glandular spaces and papillae is often confused with tumors in the common epithelial category. These retiform lesions are also less often androgenic than are other Sertoli-Leydig cell tumors. Finally, neoplasms with bizarre nuclei and tumors that occur in pregnancy, which often have prominent intercellular edema, are briefly discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8463038     DOI: 10.1097/00004347-199304000-00009

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  9 in total

1.  Cystic Sertoli-Leydig Cell Tumour in a Postmenopausal Woman with Absent Virilising Symptoms: A Diagnostic Challenge.

Authors:  Vidya Monappa; Saritha M Reddy; Ranjini Kudva; Muralidhar V Pai
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Sertoli-Leydig cell tumours of the ovary and testis: a CGH and FISH study.

Authors:  I Verdorfer; D Horst; A Höllrigl; H Rogatsch; G Mikuz
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

Review 3.  [Endocrine-active tumors of the ovary].

Authors:  H-E Stegner; Th Löning
Journal:  Pathologe       Date:  2003-06-19       Impact factor: 1.011

4.  Ovarian Sertoli-Leydig cell tumors: MRI findings and pathological correlation.

Authors:  Song-Qi Cai; Shu-Hui Zhao; Jin-Wei Qiang; Guo-Fu Zhang; Xue-Zhen Wang; Li Wang
Journal:  J Ovarian Res       Date:  2013-10-26       Impact factor: 4.234

Review 5.  [Grading of gynecological tumors : Current aspects].

Authors:  L-C Horn; D Mayr; C E Brambs; J Einenkel; I Sändig; K Schierle
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 6.  Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.

Authors:  T Burnik Papler; S Frković Grazio; B Kobal
Journal:  J Ovarian Res       Date:  2016-07-30       Impact factor: 4.234

7.  Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature.

Authors:  Trisha Plastini; Arthur Staddon
Journal:  Case Rep Med       Date:  2017-07-02

8.  [Sertoli-Leydig cell tumor of the ovary: case study of a 22-year old woman].

Authors:  Diallo Moussa; Diouf Abdoul Aziz; Diallo Astou Coly Niassy; Koulimaya Cyre Espérence; Niang Youssou; Moreau Jean Charles; Diouf Alassane
Journal:  Pan Afr Med J       Date:  2016-09-28

9.  The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.

Authors:  Yemin Wang; Jiamin Chen; Winnie Yang; Fan Mo; Janine Senz; Damian Yap; Michael S Anglesio; Blake Gilks; Gregg B Morin; David G Huntsman
Journal:  Neoplasia       Date:  2015-08       Impact factor: 5.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.